|
|
|
* - may be subscription-only |
|
|
- NextCure: First Patient Dosed in the Phase 1 Study
of LNCB74 (B7-H4 ADC) as Therapeutic for Treating
Multiple Cancers More
- Qiagen: Secures U.S. Clearance for First QIAstat-Dx
Mini Gastrointestinal Panel to Support Year-Round
Outpatient Care More
- Veralox Therapeutics: Expands Its Pipeline
With the Exclusive Option to Acquire Nudge
Therapeutics More
|
|
|
- Danaher, Artificial Intelligence Firm
Innovaccer Form Investment Partnership More*
- Life Science Review of 2024: Analyzing
Developments and Planning for Future Success Video
- LSN: Hot Investor Mandates (Updated 1/7) More
- More on Vensana Capital Keeping up Momentum With
Third Medtech Investment Fund, Raising $425M More
- Navigating JPM Week 2025: Overcoming
Challenges and Maximizing Value Video
|
|
|
|
Section
Sponsor:
|
 |
|
|
|
|
- Join Big4Bio CBO Dave Whelan in Munich for
DxPx; Save With a Special Discount Code! More
- More on Vanda CEO Penning Searing Letter to
FDA Commissioner About ‘Disturbing Pattern of
Conduct’ More
- NCI Multi-Cancer Screening Trial Set to Take Off
With Selection of Two Tests More*
- Subscribe to LifeSci
Startup for Updates on US Startups More
|
|
|
|
Section
Sponsor:
|
 |
|
|
| SECTION SPONSOR: |
 |
|
|
- Big4Bio:Capital Region Life Science Company
Directory More
|
NOTE:
EVENTS AND JOBS ARE FROM ALL BIG4BIO REGIONS
|
|
|
|
- OPPORTUNITY: Senior Director, Integrated Marketing
& Communications- REMOTE More
- OPPORTUNITY: Clinical Development Leader- New York,
NY More
- OPPORTUNITY: Sales Executive- Hybrid More
- OPPORTUNITY: Senior Director of Business Development
- Remote More
- OPPORTUNITY: Vice President of North America Medical
Affairs - MA More
- OPPORTUNITY: Vice President of
Sales & Marketing, North America- Remote More
|
|
|
|
Section
Sponsor:
|
|
|
|
|
